Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;7(3):255-64.
doi: 10.1385/NMM:7:3:255.

T-cells in Alzheimer's disease

Affiliations
Review

T-cells in Alzheimer's disease

Terrence Town et al. Neuromolecular Med. 2005.

Abstract

Alzheimer's disease (AD) is the most common dementing illness and is pathologically characterized by deposition of the 40-42 amino acid peptide, amyloid-beta (Abeta), as senile plaques. It is well documented that brain inflammatory mechanisms mediated by reactive glia are activated in response to Abeta plaques. A number of reports further suggest that T-cells are activated in AD patients, and that these cells exist both in the periphery and as infiltrates in the brain. We explore the potential role of T-cells in the AD process, a controversial area, by reviewing reports that show disturbed activation profiles and/or altered numbers of various subsets of T-cells in the circulation as well as in the AD brain parenchyma and in cerebral amyloid angiopathy. We also discuss the recent Abeta immunotherapy approach vis-à-vis the activated, autoaggressive T-cell infiltrates that contributed to aseptic meningoencephalitis in a small percentage of patients, and present possible alternative approaches that may be both efficacious and safe. Finally, we explore the use of mouse models of AD as a system within which to definitively test the possible contribution of T-cells to AD pathogenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Braz J Med Biol Res. 1998 Jan;31(1):55-60 - PubMed
    1. J Neuroimmunol. 2002 Mar;124(1-2):83-92 - PubMed
    1. Eur J Immunol. 2005 Apr;35(4):1076-85 - PubMed
    1. Neurobiol Aging. 2001 Sep-Oct;22(5):721-7 - PubMed
    1. Neuromolecular Med. 2003;3(1):29-39 - PubMed

Publication types

LinkOut - more resources